Close
  Indian J Med Microbiol
 

Figure 2: (a) Anti -human telomerase enzyme reverse transcriptase (hTERT) expression in serous cystadenocarcinoma displaying regional coarse/speckled cytoplasmic immunoreactivity (×200, scale bar = 100 μm). (b) hTERT expression in serous cystadenocarcinoma exhibiting diffuse cytoplasmic immunoreactivity (×200, scale bar = 100 μm). (c) An endometrioid adenocarcinoma that is negative for hTERT (×200, scale bar = 100 μm). (d) A mucinous borderline tumor displaying diff use hTERT nuclear and cytoplasmic immunoreactivity (×200, scale bar = 100 μm). (e) A clear cell carcinoma displaying diffuse hTERT cytoplasmic immunoreactivity (×400, scale bar = 50 μm)

Figure 2: (a) Anti -human telomerase enzyme reverse transcriptase (hTERT) expression in serous cystadenocarcinoma displaying regional coarse/speckled cytoplasmic immunoreactivity (×200, scale bar = 100 μm). (b) hTERT expression in serous cystadenocarcinoma exhibiting diffuse cytoplasmic immunoreactivity (×200, scale bar = 100 μm). (c) An endometrioid adenocarcinoma that is negative for hTERT (×200, scale bar = 100 μm). (d) A mucinous borderline tumor displaying diff use hTERT nuclear and cytoplasmic immunoreactivity (×200, scale bar = 100 μm). (e) A clear cell carcinoma displaying diffuse hTERT cytoplasmic immunoreactivity (×400, scale bar = 50 μm)